Results 201 to 210 of about 3,222 (233)
Some of the next articles are maybe not open access.
[Antiaggregant activity of hypoglycemic drugs].
Eksperimental'naia i klinicheskaia farmakologiia, 2010We have compared the inhibitory effects of a series of hypoglycemic drugs, including glyclazide, glibenclamide, glucophage, rosiglitazone, diabenol (a new antidiabetic drug), and acetylsalicylic acid (reference antiaggregant preparation), on rabbit platelet aggregation in vitro induced by adding 5 mM ADP solution.
A A, Spasov +2 more
openaire +1 more source
Platelet Antiaggregants in Pregnancy
Revista Española de Cardiología (English Edition), 2009Pablo Santiago-Díaz +3 more
openaire +1 more source
Potential Drug-Drug Interactions in Adults Receiving Oral Anticoagulant and Antiaggregant Therapy
Expert Opinion on Drug Safety, 2023Nazife Gökçe Akpınar, Sema Ketenci
exaly
[Platelet antiaggregants and coronary pathology].
La Revue du praticien, 1990Platelet inhibitors have widely been studied in various clinical situations resulting from atherosclerosis of the coronary arteries. At present, aspirin is virtually the only drug that has proved to be effective in all cases where the risk of coronary thrombosis was very high. Administered in daily doses of 160 to 1,500 mg, acetylsalicylic acid reduces
A, Castaigne +2 more
openaire +1 more source
[Anticoagulation and antiaggregation during pregnancy].
Therapeutische Umschau. Revue therapeutique, 2003For haemostatic and circulatory reasons pregnancy is associated with an about 6-fold relative increase of thrombotic risk which is further raised by additional risk factors, such as history of thrombosis or acquired and hereditary thrombophilia, respectively.
F Demarmels, Biasiutti +1 more
openaire +1 more source
[Anticoagulation and antiaggregation in cardiac patients].
Therapeutische Umschau. Revue therapeutique, 2003Aspirin treatment for primary prevention is safe and useful at an annual coronary event risk > or = 1.5%. Both aspirin and clopidogrel reduce the rate of cardiovascular events in patients with coronary disease. Clopidogrel in addition to aspirin further reduces cardiovascular events, but is associated with and increased bleeding risk. Recent studies in
openaire +1 more source
In Vitro Analysis of the Effect of Contrast Agents on the Antiaggregant Effects of P2Y12 Inhibitors
Thrombosis Research, 2019Selma Ari, Berat Uguz, Hasan Ari
exaly

